021-51111890
购物车（）
sales@molnova.cn
Alisol B
CAS No. 18649-93-9
Alisol B ( —— )
产品货号. M20406 CAS No. 18649-93-9
Alisol B 通过靶向破骨细胞的分化及其功能，可能成为一种潜在的新型骨疾病治疗分子。
纯度: >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| 规格 | 价格/人民币 | 库存 | 数量 |
| 5MG | ￥1596 | 有现货 |
|
| 10MG | ￥2373 | 有现货 |
|
| 25MG | ￥4026 | 有现货 |
|
| 50MG | ￥5613 | 有现货 |
|
| 100MG | ￥7954 | 有现货 |
|
| 200MG | 获取报价 | 有现货 |
|
| 500MG | 获取报价 | 有现货 |
|
| 1G | 获取报价 | 有现货 |
|
生物学信息
-
产品名称Alisol B
-
注意事项本公司产品仅用于科研实验，不得用于人体或动物的临床与诊断
-
产品简述Alisol B 通过靶向破骨细胞的分化及其功能，可能成为一种潜在的新型骨疾病治疗分子。
-
产品描述Alisol B may be a potential novel therapeutic molecule for bone disorders through targeting the differentiation of osteoclasts as well as their functions. Alisol B also inhibited RANKL-induced expression of NFATc1 and c-Fos which are key transcription factors for osteoclastogenesis.
-
体外实验——
-
体内实验——
-
同义词——
-
通路Others
-
靶点Other Targets
-
受体RANKL
-
研究领域——
-
适应症——
化学信息
-
CAS Number18649-93-9
-
分子量472.7
-
分子式C30H48O4
-
纯度>98% (HPLC)
-
溶解度DMSO:95 mg/mL (200.97 mM)
-
SMILES[H][C@@]1(OC1(C)C)[C@@H](O)C[C@@H](C)C1=C2C[C@H](O)[C@@]3([H])[C@@]4(C)CCC(=O)C(C)(C)[C@]4([H])CC[C@]3(C)[C@@]2(C)CC1
-
化学全称——
运输与储存
-
储存条件(-20℃)
-
运输条件With Ice Pack
-
稳定性≥ 2 years
参考文献
1.Lee J W Kobayashi Y Nakamichi Y et al. Alisol-B a novel phyto-steroid suppresses the RANKL-induced osteoclast formation and prevents bone loss in mice[J]. Biochemical Pharmacology 2010 80(3):352-361.
产品手册
关联产品
-
(-)-Epiafzelechin
(-)-Epiafzelechin exhibits significant anti-inflammatory activity on carrageenin-induced mouse paw edema, it exhibits a dose-dependent inhibition on the COX activity with an IC50 value of 15 microM, it exhibits about 3-fold weaker inhibitory potency on the enzyme activity than indomethacin as a positive control.
-
Neohesperidin
新橙皮苷具有抗氧化和神经保护特性。
-
PM 102
Peptide that reverses the anticoagulant effect of heparin. Potently binds heparin (Kd = 36 nM in vitro).
